Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Washington University School of Medicine
With
Novartis
Pfizer
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Newly diagnosed primary invasive ductal or invasive lobular breast adenocarcinoma
Tumor classified as clinically large T2 (2-5 cm), T3, T4 or any T with N1, N2
Prior malignancies: limited to curatively treated basal or squamous carcinoma of the skin or history of previous malignancies, treated and now \> 5 years disease free
\>= 18 years of age
Normal left ventricular function by echocardiogram or radioventriculogram
Karnofsky Performance \>= 70
You may not be if
No evidence of distant metastasis present by CT, Bone scan, or physical exam
If the bone scan or CT scans demonstrate indeterminate lesions, the nature of these lesions may be further clarified by additional testing such as PET or MRI
No current treatment with Zometa or other bisphosphonates
No serious functional disorders of the liver or kidneys:
Serum Creatinine \<=2
ALT/AST/ALK Phos \<= 1.5 x upper limit of institutional normal.
Bili \<= 1.5 x upper limit of institutional normal.
